NCT01447797

A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin

Single Dose Open-label Comparative Pharmacokinetic Study to Assess the Pharmacokinetic Characteristics of Irbesartan and Atorvastatin Between Irbesartan/Atorvastatin Combination Tablet and Coadministration of Irbesartan and Atorvastatin Tablets in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 52 (actual)
• Sponsor: Hanmi Pharmaceutical Company Limited · Industry
• Sex: Male
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate pharmacokinetics and safety after oral administration of Irbesartan and Atorvastatin in combination as HCP0912

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	HCP0912 / Irbesartan and Atorvastatin	Irbesartan and Atorvastatin combination tablet / coadministration of Irbesartan and Atorvastatin

Timeline

• Start date: 2011-09-01
• Primary completion: 2011-11-01
• Completion: 2011-12-01
• First posted: 2011-10-06
• Last updated: 2012-04-03

Locations

1 site across 1 country: South Korea